Narcolepsy: Diagnosis and Management

Principles and Practice of Sleep Medicine

Volumn , Issue , 2005, Pages 780-790

  Guilleminault, Christian ^a,b   Fromherz, Scott ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882897446     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B0-72-160797-7/50072-0     Document Type: Chapter

References (77)

1. Gélineau J De la narcolepsie. Gaz Hop (Paris) 1880, 53:626-628. 54:635-737.
2. Westphal C Eigenthümliche mit Einschläfen verbundene Anfälle. Arch Psychiatr 1677, 7:631-635.
3. Fisher F Epileptoide schlafzustände. Arch Psychiatr 1878, 8:200-203.
4. Henneberg R Über genuine Narkolepsie. Neurol Zbl 1916, 30:282-290.
5. Daniels L Narcolepsy. Medicine (Baltimore) 1934, 13:1-122.
6. Yoss RE, Daly DD Criteria for the diagnosis of the narcoleptic syndrome. Proc StaffMeet Mayo Clin 1957, 32:320-328.
7. Vogel G Studies in the psychophysiology of dreams: III. The dream of narcolepsy. Arch Gen Psychiatry 1960, 3:421-425.
8. Rechtschaffen A, Wolpert E, Dement WC, et al. Nocturnal sleep of narcoleptics. Electroencephalogr Clin Neurophysiol 1963, 15:599-609.
9. Takahashi Y, Jimbo M Polygraphic study of narcoleptic syndrome with special reference to hypnagogic hallucinations and cataplexy. Folia Psychiatr Neurol Jpn 1963, 7(Suppl):343-347.
10. Passouant P, Schwab RS, Cadilhac J, et al. Narcolepsie-cataplexie: Etude du sommeil de nuit et du sommeil de jour. Rev Neurol (Paris) 1964, 3:415-426.
11. Hishikawa Y, Kaneko Z Electroencephalographic study on narcolepsy. Electroencephalogr Clin Neurophysiol 1965, 18:249-258.
12. Narcolepsy 1975, Spectrum, New York. C. Guilleminault, W.C. Dement, P. Passouant (Eds.).
13. Rosen GM, Bendel AE, Neglia JP, et al. Sleep in children with neoplasms of the central nervous system: Case review of 14 children. Pediatrics 2003, 112:e46-e54.
14. Broughton R, Valley V, Aguirre M, et al. Excessive daytime sleepiness and the pathophysiology of narcolepsy-cataplexy: A laboratory perspective. Sleep 1986, 9:205-215.
15. American Academy of Sleep Medicine International Classification of Sleep Disorders: Diagnostic and Coding Manual 2005, American Academy of Sleep Medicine, Westchester, Ill. 2nd ed.
16. Guilleminault C, Heinzer R, Mignot E, et al. Investigations into the neurologic basis of narcolepsy. Neurology 1998, 50(Suppl 1):S8-S15.
17. Szucs A, Janszky J, Hollo A, et al. Misleading hallucinations in unrecognized narcolepsy. Acta Psychiatr Scand 2003, 108:314-316. discussion 316-317.
18. Guilleminault C, Pelayo R Narcolepsy in prepubertal children. Ann Neurol 1998, 43:135-142.
19. Morrish E, King MA, Smith IE, Shneerson JM Factors associated with a delay in the diagnosis of narcolepsy. Sleep Med 2004, 5:37-41.
20. Ohayon MM, Priest RG, Caucet M, et al. Hypnagogic and hypnopompic hallucinations: Pathological phenomenon?. Br J Psychiatry 1996, 169:459-467.
21. Billiard M, Besset A, Cadilhac J The clinical and polygraphic development of narcolepsy. Sleep/Wake Disorders: Natural History, Epidemiology, and Long Term Evolution 1983, 187-199. Raven Press, New York. C. Guilleminault, E. Lugaresi (Eds.).
22. Schmidt HS, Fortin LD Electronic pupillography in disorders of arousal. Sleep and Waking Disorders: Indications and Techniques 1981, 127-141. Addison-Wesley, Menlo Park, Calif. C. Guilleminault (Ed.).
23. Hoddes E, Dement WC, Zarcone V The development and use of the Stanford Sleepiness Scale (SSS). Psychophysiology 1972, 9:150.
24. Yoss RE, Mayer NJ, Ogle KN The pupillogram and narcolepsy. Neurology 1969, 19:921-928.
25. Carskadon MA, Dement WC The multiple sleep latency test: What does it measure?. Sleep 1982, 5:67-72.
26. Rechtschaffen A, Kales AD A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects 1968, UCLA Brain Information Service/Brain Research Institute, Los Angeles.
27. Association of Professional Sleep Societies, APSS Guidelines Committee; Carskadon MA, Chairperson Guidelines for the multiple sleep latency test (MSLT): A standard measure of sleepiness. Sleep 1986, 9:519-524.
28. Van den Hoed J, Kraemer H, Guilleminault C, et al. Disorders of excessive daytime somnolence: Polygraphic and clinical data for 100 patients. Sleep 1981, 4:23-38.
29. Browman CP, Gujavarty KS, Sampson MG, et al. REM sleep episodes during the maintenance of wakefulness tests in patients with sleep apnea syndrome and patients with narcolepsy. Sleep 1983, 6:23-28.
30. Broughton R, Low R, Valley V, et al. Auditory evoked potentials compared to EEG and performance measures of impaired vigilance in narcolepsy-cataplexy. Sleep Res 1981, 10:184.
31. Dauvilliers Y, Gosselin A, Paquet J, et al. Effect of age on MSLT results in patients with narcolepsy-cataplexy. Neurology 2004, 62:46-50.
32. HLA in Narcolepsy 1988, Springer-Verlag, Berlin. Y. Honda, T. Juji (Eds.).
33. Anic-Labat S, Guilleminault C, Kraemer HC, et al. Validation of a cataplexy questionnaire in 983 sleep-disorders patients. Sleep 1999, 22:77-87.
34. Moscovitch A, Partinen M, Patterson N, et al. Cataplexy in differentiation of excessive daytime somnolence. Sleep Res 1991, 20:301.
35. Mignot E, Jayduk R, Black J, et al. HLA-DQB1*0602 is associated with narcolepsy in 509 narcoleptic patients. Sleep 1997, 20:1012-1020.
36. Lin L, Faraco R, Li R, et al. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 1999, 98:365-376.
37. Chemelli RM, Willie JT, Sinton CM, et al. Narcolepsy in orexin knockout mice: Molecular genetics of sleep regulation. Cell 1999, 98:437-451.
38. Peyron C, Tighe DK, van den Pol AN, et al. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 1998, 18:9996-10015.
39. Nishino S, Ripley B, Overeem S, et al. Hypocretin (orexin) deficiency in human narcolepsy. Lancet 2000, 355:39-40.
40. Mignot E, Guilleminault C, Bowersox S, et al. Effects of alpha-1 adrenoceptor blockade with prazosin in canine narcolepsy. Brain Res 1988, 444:184-188.
41. Fruhstorfer B, Mignot E, Bowersox S, et al. Canine narcolepsy is associated with an elevated number of alpha 2 receptors in the locus coeruleus. Brain Res 1989, 500:209-214.
42. Nishino S, Haak L, Shepherd H, et al. Effects of central alpha-2 adrenergic compounds on canine narcolepsy, a disorder of rapid eye movement sleep. J Pharmacol Exp Ther 1990, 253:1145-1152.
43. Nishino S, Arrigoni J, Valtier D, et al. Dopamine D-2 mechanisms in canine narcolepsy. J Neurosci 1991, 11:2666-2671.
44. Langer SZ Presynaptic regulation of the release of catecholamines. Pharmacol Rev 1981, 32:337-362.
45. Laduron PM Presynaptic heteroreceptors in regulation of neuronal transmission. Biochem Pharmacol 1985, 34:467-470.
46. Mignot E, Guilleminault C, Dement WC, et al. Genetically determined animal models of narcolepsy, a disorder of REM sleep. Genetically-Defined Animal Models of Neurobehavioral Dysfunction 1992, 89-110. Birkhauser, Cambridge, Mass. P. Driscoll (Ed.).
47. Montplaisir J, de Champlain J, Young SN, et al. Narcolepsy and idiopathic hypersomnia: Biogenic amines and related compounds in CSF. Neurology 1982, 32:1299-1302.
48. Faull KF, Zeller-DeAmicis LC, Radde L, et al. Biogenic amine concentrations in the brains of normal and narcoleptic canines: Current status. Sleep 1986, 9:107-110.
49. Aldrich MS, Hollingsworth Z, Penney JB Dopamine-receptor autoradiography of human narcoleptic brain. Neurology 1992, 31:503-506.
50. 11C]NNC756. J Sleep Res 1996, 5:262-264.
51. 123I-IBZM. Acta Neurol Scand 1994, 90:186-189.
52. Rinne JO, Hublin C, Partinen M, et al. Positron emission tomography study of human narcolepsy: No increase in striatal dopamine D2 receptors. Neurology 1995, 45:1735-1738.
53. Aldrich MS, Prokopowicz G, Ockert K, et al. Neurochemical studies of human narcolepsy: Alpha-adrenergic receptor autoradiography of human narcoleptic brain and brainstem. Sleep 1994, 17:598-608.
54. Guilleminault C Amphetamines and narcolepsy: Use of Stanford database. Sleep 1993, 16:199-201.
55. Fry JM Treatment modalities for narcolepsy. Neurology 1998, 50(Suppl 1):S43-S48.
56. Wyatt R, Fram D, Buchbinder R, et al. Treatment of intractable narcolepsy with a monoamine oxidase inhibitor. N Engl J Med 1971, 285:987-999.
57. Scharf MB, Brown D, Woods M, et al. The effects and effectiveness of gamma-hydroxybutyrate in patients with narcolepsy. J Clin Psychol 1985, 46:222-225.
58. Lammers GJ, Arends J, Declerk AC, et al. Gammahydroxybutyrate and narcolepsy: A double-blind placebo-controlled study. Sleep 1993, 16:216-220.
59. Broughton R, Mamelak M The treatment of narcolepsy-cataplexy with nocturnal gamma hydroxybutyrate. Can J Neurol Sci 1979, 6:1-6.
60. Mamelak M, Scharf MB, Woods M Treatment of narcolepsy with gamma-hydroxybutyrate: A review of clinical and sleep laboratory findings. Sleep 1986, 9:285-289.
61. U.S. Xyrem Multicenter Study Group: A randomized, double blind, multicenter trial comparing the effect of 3 doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy. Sleep 2002, 25:42-49.
62. Borgen LA, Okerholm RA, Lai A, Scharf MB The pharmacokinetics of sodium oxybate oral solution following acute and chronic administration to narcoleptic patients. J Clin Pharmacol 2004, 44:253-257.
63. Guilleminault C, Mancuso J, Quera Salva MA, et al. Viloxazine hydrochloride in narcolepsy: A preliminary report. Sleep 1986, 9:275-279.
64. Langdon N, Bandak S, Shindler J, et al. Fluoxetine in the treatment of cataplexy. Sleep 1986, 9:371-372.
65. Mitler MM, Hajdukovic R Relative efficacy of drugs for the treatment of sleepiness in narcolepsy. Sleep 1991, 14:218-220.
66. Bedart MA, Montplaisir J, Godbout R Effect of L-dopa on periodic movements in sleep in narcoleptics. Eur Neurol 1987, 27:35-38.
67. Boivin MA, Montplaisir J, Poirier G The effect of L-dopa on periodic leg movements and sleep organization in narcolepsy. Clin Neuropharmacol 1989, 12:29-37.
68. Parkes JD Amphetamines and alertness. Narcolepsy 1976, 643-657. Spectrum, New York. C. Guilleminault, W.C. Dement, P. Passouant (Eds.).
69. Prinzmetal M, Bloomberg W The use of benzedrine for treatment of narcolepsy. JAMA 1935, 105:2051-2054.
70. Honda Y, Hishikawa Y Effectiveness of pemoline in narcolepsy. Sleep Res 1970, 8:192.
71. U. S. Modafinil in Narcolepsy Study Group: Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy. Ann Neurol 1998, 43:88-97.
72. Mitler M, Erman M, Hajdukovic R The treatment of excessive somnolence with stimulant drugs. Sleep 1993, 16:203-206.
73. Parkes JD, Dahlitz M Amphetamine prescription. Sleep 1993, 16:201-203.
74. Parkes JD, Schacter M Mazindol in the treatment of narcolepsy. Acta Neurol Scand 1979, 60:250-254.
75. Boutrel B, Koob GF What keeps us awake: The neuropharmacology of stimulants and wakefulness-promoting medications. Sleep 2004, 27:1181-1194.
76. U. S. Xyrem Multicenter Study Group: Sodium oxybate demonstrates long-term efficacy for the treatment of cataplexy in patients with narcolepsy. Sleep Med 2004, 5:119-123.
77. Yoss RE, Daly DD Treatment of narcolepsy with Ritalin. Neurology 1959, 9:171-173.